Mastodawn

daniel Feb 10, 2024

CDC issues travel notice for #Brazil due to #Oropouche fever outbreak

https://outbreaknewstoday.substack.com/p/cdc-issues-travel-notice-for-brazil

CDC issues travel notice for Brazil due to Oropouche fever outbreak

Just days after the Pan American Health Organization (PAHO) published an Epidemiological Alert for an increase in the detection of cases of Oropouche fever cases in parts of South America, the Centers for Disease Control and Prevention (CDC) issued a travel notice for travelers to Amazonas and Acre states in Brazil.

Outbreak News Today

daniel Sep 19, 2023

#Arthropod-borne viruses, such as #dengue, #Zika, and #Mayaro, are emerging at an accelerating rate in the neotropics of central and south America.

#TravelMedicine #Latinoamérica #LatinAmerica #IDMastodon #EmergingInfections #GlobalHealth

https://www.scienceopen.com/hosted-document?doi=10.15212/ZOONOSES-2022-0047

The Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics (CREATE-NEO)

Arthropod-borne viruses, such as dengue, Zika, and Mayaro, are emerging at an accelerating rate in the neotropics. The Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics (CREATE-NEO) project, a part of the NIH-funded Centers for Research in Emerging Infectious Diseases (CREID) network provides a nimble and flexible network of surveillance sites in Central and South America coupled with cutting-edge modeling approaches to anticipate and counter these threats to public health. Collected data and generated models will be utilized to inform and alert local, regional, and global public health agencies of enzootic arboviruses with a high risk of spillover, emergence, and transmission among humans, and/or international spread. CREATE-NEO builds capacity in situ to anticipate, detect, and respond to emerging arboviruses at the point of origin, thereby maximizing the potential to avert full-blown emergence and widespread epidemics.

ScienceOpen

daniel Aug 30, 2023

New vaccines on the horizon for travellers: #chikungunya and #dengue

#TravelMedicine #VaccinesWork #IDMastodon

https://link.springer.com/article/10.1007/s11908-023-00811-x

New Vaccines on the Immediate Horizon for Travelers: Chikungunya and Dengue Vaccines - Current Infectious Disease Reports

Purpose of Review Both chikungunya and dengue virus infections are frequent in international travelers to endemic areas. Recent Findings More than 11 chikungunya vaccines are in development, with one having completed phase 3 trials using a single dose, based on immune correlates as endpoint. Two live attenuated dengue vaccines are now licensed for use in travelers. Dengvaxia can only be used following pre-vaccination screening for serostatus, while Qdenga is licensed without the need for pre-vaccination screening, as the vaccine performance is less determined by serostatus. However, also for Qdenga, the efficacy is higher in seropositive persons against all four serotypes, while in seronegative persons, Qdenga only protects against serotypes 1 and 2. Summary Use of vaccines to protect against chikungunya and dengue is a high priority in the travel medicine context. Development of a chikungunya vaccine is scientifically less challenging compared to dengue vaccines. However, the risk of dengue is consistently much higher in travelers over the past decades, while risk assessment is more challenging for chikungunya given the sporadicity and unpredictability of chikungunya outbreaks.

SpringerLink

daniel Mar 29, 2023

Zero by 2030 and #OneHealth: The challenges of #rabies control and elimination

#TMAID #TravelMedicine #IDMastodon

https://www.sciencedirect.com/science/article/pii/S1477893922002551

Show thread

Busy Bee Jan 2, 2023

@noamross I so wish I could apply for this position, but I haven’t finished my MPH yet and need more stats training. I’m currently supporting a project on disease modeling for travel that is being challenged for funding, and it’s such important work to do. Best of luck filling the position; I can’t wait to see the resulting work published. #datascience #travelmedicine

Larapayne85 Nov 20, 2022

#introduction
Hello #med-mastodon, I’m an Infectious Diseases and Microbiology trainee in London. Passionate about #Globalhealth and #equity.
Hoping to read new content sparking ideas and connections. I trained in Brighton, London and Cairns.
#IDMastodon
#ClinMicroMastadon
#MedEd
#STEM
#decolonializeglobalhealth
#Feminist
#ADHD
#dyslexia
#AntiFascist
#antiracism
#NTDs
#academia
#academicchatter
#Parasitology
#Mycology
#Travelmedicine
#HIVMastodon
#londoninfectionrep
#TAEescmid
#academicmom

Raoul Breugelmans Nov 7, 2022

日本旅行医学会で第14回看護部会の参加申し込み受付中です。
お申し込み締切は11/16（水）正午までです。

ご興味のある方は詳細ページをご覧ください：
http://jstm.gr.jp/?p=3995

概要
タイトル：第14回日本旅行医学会看護部会
日時： 2022年11月20日（日） 10：30～15：25
会場：オンライン（Zoom）
主催：日本旅行医学会

プログラム
■10:30～10:35 プレレクチャー　看護師の旅行医学
■10:35～11:30 【海外トピックス】『モーリシャスの医療制度の特徴、日本との違い』
■11:40～12:30 【教育講演１】『看護師の業務範囲と法的責任』
■13:20～14:20 【体験発表＆ディスカッション】『ナースとして新型コロナで困ったこと、新型コロナ対策のナースとしての工夫　など』
■14:30～15:20 【教育講演2】『喘息児の旅行医学』
■15:20～15:25 閉会挨拶

#TravelMedicine #JapanSocietyOfTravelMedicine #JSTM #日本旅行医学会 #旅行医学 #看護部会